| |
Welcome
to Wantai Biological Pharmacy Enterprise Co., Ltd |
|
| |
The official supplier of HIV blood screening
reagents in China.
The Chinese market-leader for infectious diseases diagnostic test
|
History |
 1991- Establishment
1999- GMP certified (the first IVD company in China)
1999- Introduced the first China-made 3rd generation HIV ELISA
2001- Merger with YST Group
2003- Introduced the first China-made HIV Rapid Test
2004- Introduced HEV IgM ELISA (capture method)
2005- Hepatitis E vaccine, completed phase-II clinical trial
2005- Relocated to a new state-of-the-art facility
2006- Reached sales of 10,000 HIV ELISA kits per month
2007- Hepatitis E vaccine, beginning of phase-III clinical trial
2007- Establishment of DERUI subsidiary(clinical biochemistry) |
| This is Wantai |
Founded in 1991 and developed from a small laboratory, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a leading Chinese in vitro diagnostic reagents manufacturer.Wantai is located at Zhongguancun Life Science Park - the biotechnology heart of Beijing now.
Most of our ELISA kits are batch-released by the National Institute for the Control of Pharmaceutical and Biological Products(NICPBP) in China before market release. Each diagnostic kit is rigorously tested to ensure it meets our high quality standards and your satisfaction.
We cooperate closely with famous biological institutes, business units and organizations in China and the rest of the world.
Our key partners include: State Laboratory for Tumor Cell Engineering of Xiamen University, NIDVD, BIO-RAD, etc. We believe that extensive cooperation and exchange with the world is one of the driving forces to strive to success.
|
Wantai provides diagnostic products within the following areas:
Blood-born pathogens screening
Clinical diagnosis of infectious diseases
Screening of blood-derived products for infectious diseases
Diseases prevention
Our products are:
ELISA kits for diagnosis and screening of infectious diseases
Rapid colloidal
gold chromatographic tests
Recombinant
vaccines Most of our ELISA test kits are batch-released by the National
Institute for the Control of Pharmaceutical and Biological Products
(NICPBP) before market release.
Our clients are:
Blood banks
Hospitals
Research and
specialized laboratories
State health
organizations
Reference State
centers
|
| |
| In collaboration with scientific
institutions and companies in China and the world, we have brought
several unique products to the market:
HIV 1+2 ELISA
- The first China-made double antigen ˇ°sandwichˇ± assay, the current
domestic market leader in the field of blood supply safety
HIV 1+2 rapid
Test ¨C The first China-made HIV Rapid Test
HTLV 1+2 ELISA
- double antigen ˇ±sandwichˇ± assay
anti-TP ELISA
- double antigen ˇ±sandwichˇ± assay
hepatitis E
IgM ELISA ¨C antibody capture assay
Our key partners include: State Laboratory for Tumor Cell Engineer
of Xiamen University, Microbiology Department of Hong Kong University.,
etc.
|
| |
| |
|
| |
|
| |
.jpg)
